✦ LIBER ✦

Brief report: Validation of a reinforcer survey for use with geriatric patients

✍ Scribed by Daniel Houlihan; Rochelle Rodriguez; Howard D. Levine; Jill Kloeckl

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 544 KB
Volume: 5
Category: Article
ISSN: 1072-0847
DOI: 10.1002/bin.2360050207

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

This paper describes a Geriatric Reinforcer Survey (GRS) which expands upon a previous Reinforcement Survey Schedule (RSS) developed by Cautela and Kastenbaum (1967). The GRS, an instrument designed to quickly assess reinforcer preference in geriatric populations, has two formats, one for individuals over 65 years of age who are still able to comprehend and write, and one designed to be filled out by relatives and staff familiar with an individual over 65 years of age who can no longer comprehend or write well. Reinforcer preference was determined by giving the GRS to a total of 107 geriatric persons in both home and institutional settings. Test‐retest reliability was assessed on a subsample of 71 individuals over a 10‐14‐day period and was found to be r~s~ = 0.608, p <0.01 using the Spearman Rank‐Order Correlation Coefficient. This indicated that the GRS had reasonable test‐retest reliability. The validity of having a relative or familiar staff person fill out the GRS for a specific individual was also tested. Results of 43 administrations of the GRS to relatives of a geriatric person, using the Spearman Rank‐Order Correlation Coefficient, showed a correlation of r~s~ = 0.488, p <0.01 when the responses of that person were compared to those of the individual. Results of 17 administrations of the GRS to staff familiar with a particular patient were r~s~ = 0.436, p < 0.05 when compared to responses made by the individual. This indicates that the GRS might be useful in structuring interventions for individuals who are incapacitated, and groups of geriatric persons. The GRS also has the potential to be a valuable research tool.

📜 SIMILAR VOLUMES

A pilot study of the vulnerable elders s

A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation

✍ Supriya G. Mohile; Kathryn Bylow; William Dale; James Dignam; Kandis Martin; Dan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract ## BACKGROUND. Impairments in geriatric domains adversely affect health outcomes of the elderly. The Comprehensive Geriatric Assessment (CGA) is a key component of the treatment approach for older cancer patients, but it is time consuming. In this pilot study, the authors evaluated the

Validation and adaptation of a nomogram

Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system

✍ Luigi Mariani; Rosalba Miceli; Michael W. Kattan; Murray F. Brennan; Maurizio Co 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

Rasburicase (recombinant urate oxidase)

Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer : Report of an International Compassionate Use Study

✍ André Bosly; Anne Sonet; C. Ross Pinkerton; Geoffrey McCowage; Dominique Bron; M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## BACKGROUND Hyperuricemia and tumor lysis syndrome (TLS) are serious complications that can occur during chemotherapy for hematologic malignancies, even if standard management procedures, including administration of allopurinol, are undertaken. Rasburicase, a recombinant urate oxidas

Attitudes of medical oncologists toward

Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer : Report on a survey by the European Society of Medical Oncology taskforce on palliative and supportive care

✍ Nathan I. Cherny; Raphael Catane 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Background and methods: In part of a quality improvement program, the european society of medical oncology (esmo) surveyed its membership regarding their involvement in and attitudes toward the palliative care (pc) of patients with advanced cancer. ## Results: Of 895 members who responded, 82.

Acute and Chronic Toxicity of Veratrum V

Acute and Chronic Toxicity of Veratrum Viride††The Veratrum viride studied was the whole-powdered drug marketed by Irwin, Neisler & Co. under the name, Vertavis. The work reported herein was supported by a grant from this firm. The batch of powder used in these experiments was stated by the manufacturer to have been assayed biologically by the Craw method on Daphnia magna. One Craw unit of the material studied was stated to be 15.6mg. With regard to this assay, Mr. R. O. Craw has been so kind as to allow us to publish a brief explanation: A reference lot of Yerolrum oirid; powder was set-aside as a standard and a 10% w/v aqueous extract was made of this powder. The average median length of life in 50 assays of 1000 daphnia on immersion in the solution was determined to be 2.22 hours. The daphnia were considered dead when the heart was found to be in systolic standstill on microscopic examination. Succeeding lots of powder were assayed and their potency determined by relating the median length of life of daphnia to 2.22 hours, which is one unit. Twenty assays of 10 animals each were used on each lot of powder.‡‡The authors wish to thank Dr. J. F. A.,McManus of the Department of Pathology for a pathologic report on the tissues, and Mr. James Thomas and Mrs. Bobby E. Teague for technical assistance.

✍ Perdue, Adoline S. ;Bell, Frances ;Starnes, W.R. ;Hitchcock, Philip ;Teague, R.S 📂 Article 📅 1950 🏛 Elsevier ⚖ 346 KB 👁 1 views